Fractyl Health (GUTS) Change in Accured Expenses (2023 - 2026)
Fractyl Health (GUTS) reported Change in Accured Expenses of -$2.9 million for Q1 2026, down 475.51% year-on-year from $780000.0 in Q1 2025, and down 1633.14% quarter-over-quarter from -$169000.0 in Q4 2025.
Fractyl Health (GUTS) has 4 years of Change in Accured Expenses data on file, last reported at -$2.9 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses fell 475.51% year-over-year to -$2.9 million; the trailing twelve-month figure through Mar 2026 stood at -$3.3 million (down 192.04% YoY), and the FY2025 full-year result was $414000.0, down 92.68% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$2.9 million, down from -$169000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.9 million in Q1 2024 and bottomed at -$2.9 million in Q1 2026.
- A 4-year average of $283230.8 and a median of $367000.0 in 2023 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses surged 2430.77% in 2024 and tumbled 475.51% in 2026, its largest moves.
- Tracing GUTS's Change in Accured Expenses over 4 years: stood at $367000.0 in 2023, then jumped by 613.35% to $2.6 million in 2024, then sank by 106.46% to -$169000.0 in 2025, then slumped by 1633.14% to -$2.9 million in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$2.9 million, -$169000.0, and -$811000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 107.70 Mn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | -2.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.93 Mn |
| Mar 31, 2026 | -2.93 Mn |
| Dec 31, 2025 | -169,000.00 |
| Dec 31, 2025 | -169,000.00 |
| Sep 30, 2025 | -811,000.00 |
| Sep 30, 2025 | -811,000.00 |
| Jun 30, 2025 | 614,000.00 |
| Jun 30, 2025 | 614,000.00 |
| Mar 31, 2025 | 780,000.00 |
| Mar 31, 2025 | 780,000.00 |
| Dec 31, 2024 | 2.62 Mn |
| Dec 31, 2024 | 2.62 Mn |
| Sep 30, 2024 | 1.97 Mn |
| Sep 30, 2024 | 1.97 Mn |
| Jun 30, 2024 | -1.79 Mn |
| Jun 30, 2024 | -1.79 Mn |
| Mar 31, 2024 | 2.85 Mn |
| Mar 31, 2024 | 2.85 Mn |
| Dec 31, 2023 | 367,000.00 |
| Dec 31, 2023 | 367,000.00 |
| Sep 30, 2023 | 78,000.00 |
| Sep 30, 2023 | 78,000.00 |
| Jun 30, 2023 | -867,000.00 |
| Jun 30, 2023 | -867,000.00 |
| Mar 31, 2023 | 965,000.00 |
| Mar 31, 2023 | 965,000.00 |